Excess mortality associated with the COVID-19 pandemic during the 2020 and 2021 waves in Antananarivo, Madagascar.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
07 2023
Historique:
received: 18 01 2023
accepted: 17 06 2023
medline: 28 7 2023
pubmed: 27 7 2023
entrez: 26 7 2023
Statut: ppublish

Résumé

COVID-19-associated mortality remains difficult to estimate in sub-Saharan Africa because of the lack of comprehensive systems of death registration. Based on death registers referring to the capital city of Madagascar, we sought to estimate the excess mortality during the COVID-19 pandemic and calculate the loss of life expectancy. Death records between 2016 and 2021 were used to estimate weekly excess mortality during the pandemic period. To infer its synchrony with circulation of SARS-CoV-2, a cross-wavelet analysis was performed. Life expectancy loss due to the COVID-19 pandemic was calculated by projecting mortality rates using the Lee and Carter model and extrapolating the prepandemic trends (1990-2019). Differences in life expectancy at birth were disaggregated by cause of death. Peaks of excess mortality in 2020-21 were associated with waves of COVID-19. Estimates of all-cause excess mortality were 38.5 and 64.9 per 100 000 inhabitants in 2020 and 2021, respectively, with excess mortality reaching ≥50% over 6 weeks. In 2021, we quantified a drop of 0.8 and 1.0 years in the life expectancy for men and women, respectively attributable to increased risks of death beyond the age of 60 years. We observed high excess mortality during the pandemic period, in particular around the peaks of SARS-CoV-2 circulation in Antananarivo. Our study highlights the need to implement death registration systems in low-income countries to document true toll of a pandemic.

Identifiants

pubmed: 37495370
pii: bmjgh-2023-011801
doi: 10.1136/bmjgh-2023-011801
pmc: PMC10373673
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCIRD CDC HHS
ID : U51 IP000812
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Br J Anaesth. 2022 Apr;128(4):e279-e281
pubmed: 35151463
Nature. 2023 Jan;613(7942):130-137
pubmed: 36517599
Int J Epidemiol. 2021 Jan 23;49(6):1909-1917
pubmed: 33053172
Epidemiol Infect. 2013 Apr;141(4):745-50
pubmed: 22814442
Oecologia. 2008 May;156(2):287-304
pubmed: 18322705
Pan Afr Med J. 2020 Mar 19;35:84
pubmed: 32537087
Lancet Glob Health. 2021 Oct;9(10):e1363-e1364
pubmed: 34534478
BMC Public Health. 2022 Apr 12;22(1):724
pubmed: 35413894
Ann Epidemiol. 2014 Aug;24(8):575-80, 580.e1
pubmed: 24970490
Influenza Other Respir Viruses. 2021 Jul;15(4):457-468
pubmed: 33586912
Public Health Rep (1896). 1963 Jun;78(6):494-506
pubmed: 19316455
Stat Med. 2013 Mar 30;32(7):1206-22
pubmed: 22941770
Biol Sex Differ. 2020 May 25;11(1):29
pubmed: 32450906
Popul Health Metr. 2019 Jul 29;17(1):8
pubmed: 31357994
Nat Hum Behav. 2022 Dec;6(12):1649-1659
pubmed: 36253520
Clin Infect Dis. 2022 Aug 24;75(1):e1188-e1191
pubmed: 34657152
Lancet Glob Health. 2022 Feb;10(2):e195-e206
pubmed: 35063111
Int J Epidemiol. 2022 Feb 18;51(1):63-74
pubmed: 34564730
Molecules. 2020 Nov 12;25(22):
pubmed: 33198318
Public Health. 2022 Feb;203:19-22
pubmed: 35016071
Int J Infect Dis. 2021 Feb;103:338-342
pubmed: 33249289
BMJ. 2021 May 19;373:n1137
pubmed: 34011491
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Demography. 1984 Feb;21(1):83-96
pubmed: 6714492
PLoS Negl Trop Dis. 2021 Dec 20;15(12):e0010064
pubmed: 34928955
Epidemics. 2022 Mar;38:100533
pubmed: 34896895
Lancet Infect Dis. 2019 May;19(5):537-545
pubmed: 30930106
Lancet. 2022 Apr 16;399(10334):1513-1536
pubmed: 35279232
BMJ. 2021 Feb 17;372:n334
pubmed: 33597166
Lancet. 2015 Aug 22;386(9995):729-30
pubmed: 26333961
Nat Med. 2021 Sep;27(9):1629-1635
pubmed: 34188224

Auteurs

Joelinotahiana Hasina Rabarison (JH)

Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Jean Marius Rakotondramanga (JM)

Institut Pasteur de Madagascar, Antananarivo, Madagascar.
UMMISCO, Bondy, France.

Rila Ratovoson (R)

Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Bruno Masquelier (B)

Universite Catholique de Louvain Centre de recherche en demographie et societes, Louvain la neuve, Belgium.

Anjaraso Maharavo Rasoanomenjanahary (AM)

Bureau Municipal d'Hygiène, Commune Urbaine d'Antananarivo, Antananarivo, Madagascar.

Anou Dreyfus (A)

Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Andres Garchitorena (A)

Institut Pasteur de Madagascar, Antananarivo, Madagascar.
UMR 224 MIVEGEC, IRD, Montpellier, France.

Fidisoa Rasambainarivo (F)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, New Jersey, USA.
Mahaliana Labs SARL, Antananarivo, Madagascar.

Norosoa Harline Razanajatovo (NH)

Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Soa Fy Andriamandimby (SF)

Institut Pasteur de Madagascar, Antananarivo, Madagascar.

C Jessica Metcalf (CJ)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, New Jersey, USA.

Vincent Lacoste (V)

Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Jean-Michel Heraud (JM)

Institut Pasteur de Madagascar, Antananarivo, Madagascar jean-michel.heraud@pasteur.fr.
Institut Pasteur de Dakar, Dakar, Senegal.

Philippe Dussart (P)

Institut Pasteur de Madagascar, Antananarivo, Madagascar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH